➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Harvard Business School
Colorcon
Dow
Express Scripts

Last Updated: March 7, 2021

DrugPatentWatch Database Preview

Shire Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SHIRE, and what generic and branded alternatives to SHIRE drugs are available?

SHIRE has twenty-five approved drugs.



Drugs and US Patents for Shire

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire PRO-BANTHINE propantheline bromide TABLET;ORAL 008732-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Shire SUPPRELIN histrelin acetate INJECTABLE;INJECTION 019836-003 Dec 24, 1991 DISCN No No   Start Trial   Start Trial
Shire PRO-BANTHINE propantheline bromide TABLET;ORAL 008732-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Shire Llc SALURON hydroflumethiazide TABLET;ORAL 011949-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Shire BANTHINE methantheline bromide TABLET;ORAL 007390-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Shire Richwood X-TROZINE L.A. phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 087371-001 Aug 24, 1982 DISCN No No   Start Trial   Start Trial
Shire FUROXONE furazolidone SUSPENSION;ORAL 011323-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Shire

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-003 Jun 19, 1990 3,740,395   Start Trial
Shire SUPPRELIN histrelin acetate INJECTABLE;INJECTION 019836-001 Dec 24, 1991 4,244,946   Start Trial
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-001 Jun 19, 1990 3,740,395   Start Trial
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-002 Jun 19, 1990 3,740,395   Start Trial
Shire SUPPRELIN histrelin acetate INJECTABLE;INJECTION 019836-002 Dec 24, 1991 4,244,946   Start Trial
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150-001 Aug 25, 2011 5,648,333   Start Trial
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-003 Jun 19, 1990 3,864,487   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for SHIRE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 10 mg/mL ➤ Subscribe 2015-08-25
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Dow
AstraZeneca
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.